Vector and Nammo Defense Systems partner to produce NDAA-compliant, kinetically-integrated UAS platforms for small-drone battlefield deployment.

Welcome to Edition 8.31 of the Rocket Report! We have some late-breaking news this week with an update Thursday afternoon ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

CrossAmerica Partners L.P. Annual cash flow by MarketWatch. View CAPL net cash flow, operating cash flow, operating expenses and cash dividends.

Explore the SGX:CAPL financials. Find the Capallianz Holdings financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key ...

About CrossAmerica Partners L.P. CrossAmerica Partners LP engages in the business of wholesaling distribution of motor fuel, convenience store operation, and the ownership and leasing of real estate ...

The Caplin Point Laboratories Ltd EPS (TTM) is 80.50. When Is The Next Caplin Point Laboratories Ltd Earnings Date? Caplin Point Laboratories Ltd will release its next earnings report on May 14, 2026.

For immediate concerns about closed captioning of broadcast programs or online video content during weekday business hours 8 a.m.-5 p.m., call David Harpe at (303) 830-6426 or e-mail ...

The Yellow Ribbon Program is a provision of the Post-9/11 GI Bill that can help students attend expensive private schools at little or no cost to themselves. Normally, Post-9/11 GI Bill payments at ...

The Global Wildlife Program (GWP), funded by the Global Environment Facility (GEF) and led by the World Bank, is one of the largest global partnerships addressing wildlife poaching, trafficking, and ...

TIOBE Index for February 2026: Top 10 Most Popular Programming Languages Your email has been sent February’s TIOBE Index shows a leaderboard that looks steady at first glance, but small shifts beneath ...

AAV-based gene therapies hold promise for treating disease, but their long-lasting gene expression limits their use in regenerative medicine. A study now presents DreAM, a drug-inducible AAV system ...